Skip to main content
Clinical Trials/NCT02531347
NCT02531347
Completed
Not Applicable

Treatment of Hypertension Using Telemedical Home Blood Pressure Measurements

Erling Bjerregaard Pedersen0 sites375 target enrollmentMarch 2011
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Erling Bjerregaard Pedersen
Enrollment
375
Primary Endpoint
Blood pressure reduction
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of the study is to compare antihypertensive treatment based on either conventional blood pressure measurements or telemedical home blood pressure measurements.

Hypothesis is that telemedical treatment of hypertension is more effective in lowering blood pressure, is more cost-effective and provides better quality of life.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
December 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Erling Bjerregaard Pedersen
Responsible Party
Sponsor Investigator
Principal Investigator

Erling Bjerregaard Pedersen

Professor, Chief Physician

Regional Hospital Holstebro

Eligibility Criteria

Inclusion Criteria

  • Age 55 to 64 years
  • Registered address in the Municipality of Holstebro
  • Enrolment at a practice of one of the general practitioners who had agreed to participate in the study
  • Telemedical home blood pressure measurement with ≥12 measurements on day 2 and
  • Elevated home blood pressure ≥135/85 (if diagnosed diabetes, chronic kidney disease or prior stroke ≥130/80)
  • Hypertension confirmed by daytime ambulatory blood pressure ≥135/85 (if diagnosed diabetes, chronic kidney disease or prior stroke ≥130/80)
  • ECG verified sinus rhythm

Exclusion Criteria

  • Unwillingness to participate
  • Normotension
  • Withdrawal of consent to participate

Outcomes

Primary Outcomes

Blood pressure reduction

Time Frame: 3 month

Difference in daytime ambulatory blood pressure from baseline to followup between intervention and control group

Secondary Outcomes

  • Number of patients reaching target blood pressure(3 month)

Similar Trials